Detection of disseminated tumor cells in neuroblastoma -: 3 log improvement in sensitivity by automatic immunofluorescence plus FISH (AIPF) analysis compared with classical bone marrow cytology

被引:32
作者
Méhes, G
Luegmayr, A
Kornmüller, R
Ambros, IM
Ladenstein, R
Gadner, H
Ambros, PF
机构
[1] St Anna Childrens Hosp, Childrens Canc Res Inst, A-1090 Vienna, Austria
[2] Univ Pecs, Dept Pathol, Sch Med, St Anna Childrens Hosp, Vienna, Austria
关键词
POLYMERASE CHAIN-REACTION; HYDROXYLASE MESSENGER-RNA; STAGE-IV NEUROBLASTOMA; NEURO-BLASTOMA; METASTATIC NEUROBLASTOMA; MULTIVARIATE-ANALYSIS; RT-PCR; GD2; GANGLIOSIDE; BLOOD;
D O I
10.1016/S0002-9440(10)63669-3
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The sensitive detection of bone marrow involvement is crucial for tumor staging at diagnosis and for monitoring of the therapeutic response in the patient's follow-up. in neuroblastoma, only conventional cytomorphological techniques are presently accepted for the detection of bone marrow involvement, yet since the therapeutic consequences of the bone marrow findings may be far-reaching, the need for highly reliable detection methods has become evident. For this purpose, we developed an automatic immunofluorescence plus FISH (AIPF) device which allows the exact quantification of disseminated tumor cells and the genetic verification in critical cases. in this study, the power of the immunofluorescence technique is compared with conventional cytomorphology. 198 samples from 23 neuroblastoma patients (stages 4 and 4s) at diagnosis and during follow-up were investigated. At diagnosis, 45.6% of the samples (26 of 57) which were positive by AIPF investigation were negative by cytomorphology. During follow-up, 74.2% (49 of 66) of AIPF-positive samples showed no cytological signs of tumor cell involvement. False negative morphological results were found in up to 10% of tumor cell content. A tumor cell infiltrate below 0.1% was virtually not detectable by conventional cytomorphology. Using the sensitive immunofluorescence technique, the analysis of only two instead of four puncture sites did not lead to false negative results. Thus, the immunofluorescence technique offers an excellent tool for reliable detection and quantification of disseminated tumor cells at diagnosis and during the course of the disease.
引用
收藏
页码:393 / 399
页数:7
相关论文
共 36 条
[1]   Pathology and biology guidelines for resectable and unresectable neuroblastic tumors and bone marrow examination guidelines [J].
Ambros, PF ;
Ambros, IM .
MEDICAL AND PEDIATRIC ONCOLOGY, 2001, 37 (06) :492-504
[2]  
Ambros PF, 2001, MED PEDIATR ONCOL, V36, P1
[3]   Unequivocal identification of disseminated tumor cells in the bone marrow by combining immunological and genetic approaches -: functional and prognostic information [J].
Ambros, PF ;
Méhes, G ;
Hattinger, C ;
Ambros, IM ;
Luegmayr, A ;
Ladenstein, R ;
Gadner, H .
LEUKEMIA, 2001, 15 (02) :275-277
[4]  
AMBROS PF, 1998, MED PEDIATR ONCOL, V31, P195
[5]   DETECTION OF MINIMAL DISEASE IN BONE-MARROW OF NEURO-BLASTOMA PATIENTS BY IMMUNOFLUORESCENCE [J].
BERTHOLD, F ;
SCHNEIDER, A ;
SCHUMACHER, R ;
BOSSLET, K .
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 1989, 6 (02) :73-83
[6]  
Borgen E, 1998, J PATHOL, V185, P427, DOI 10.1002/(SICI)1096-9896(199808)185:4<427::AID-PATH127>3.0.CO
[7]  
2-7
[8]   Gain of chromosome arm 17q and adverse outcome in patients with neuroblastoma [J].
Bown, N ;
Cotterill, S ;
Lastowska, M ;
O'Neill, S ;
Pearson, ADJ ;
Plantaz, D ;
Meddeb, M ;
Danglot, G ;
Brinkschmidt, C ;
Christiansen, H ;
Laureys, G ;
Speleman, F .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (25) :1954-1961
[9]   INTERNATIONAL CRITERIA FOR DIAGNOSIS, STAGING, AND RESPONSE TO TREATMENT IN PATIENTS WITH NEURO-BLASTOMA [J].
BRODEUR, GM ;
SEEGER, RC ;
BARRETT, A ;
BERTHOLD, F ;
CASTLEBERRY, RP ;
DANGIO, G ;
DEBERNARDI, B ;
EVANS, AE ;
FAVROT, M ;
FREEMAN, AI ;
HAASE, G ;
HARTMANN, O ;
HAYES, FA ;
HELSON, L ;
KEMSHEAD, J ;
LAMPERT, F ;
NINANE, J ;
OHKAWA, H ;
PHILIP, T ;
PINKERTON, CR ;
PRITCHARD, J ;
SAWADA, T ;
SIEGEL, S ;
SMITH, EI ;
TSUCHIDA, Y ;
VOUTE, PA .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (12) :1874-1881
[10]   EARLY CLINICAL-EVALUATION OF NEUROBLASTOMA CELL DETECTION BY REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION (RT-PCR) FOR TYROSINE-HYDROXYLASE MESSENGER-RNA [J].
BURCHILL, SA ;
BRADBURY, FM ;
SELBY, P ;
LEWIS, IJ .
EUROPEAN JOURNAL OF CANCER, 1995, 31A (04) :553-556